Pefloxacin Mesylate Dihydrate

CAS No. 149676-40-4

Pefloxacin Mesylate Dihydrate( Pefloxacin Mesylate Dihydrate; Pefloxacin (mesylate dihydrate); Peflacin )

Catalog No. M12077 CAS No. 149676-40-4

Pefloxacin mesylate dehydrate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse).

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100mg 113 In stock
50mg 76 In stock
25mg 51 In stock

Biological Information

  • Product Name
    Pefloxacin Mesylate Dihydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Pefloxacin mesylate dehydrate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse).
  • Description
    Pefloxacin mesylate dehydrate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse).
  • Synonyms
    Pefloxacin Mesylate Dihydrate; Pefloxacin (mesylate dihydrate); Peflacin
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Topoisomerase
  • Recptor
    Topo II
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    149676-40-4
  • Formula Weight
    465.49
  • Molecular Formula
    C17H20FN3O3·CH4O3S·2H2O
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 67 mg/mL (143.93 mM); DMSO: 9 mg/mL (19.33 mM)
  • SMILES
    CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O.O.O
  • Chemical Name
    1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;methanesulfonic acid;dihydrate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bergogne-Bérézin E, et al. Int J Antimicrob Agents. 1991;1(1):29-46.
molnova catalog
related products
  • Mitoxantrone hydroch...

    Mitoxantrone Dihydrochloride, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.

  • Wogonoside

    Wogonoside acts as apositive allosteric modulatorof thebenzodiazepine site of theGABAAreceptor.

  • SN-38

    LE-SN38 is NeoPharm’s NeoLipid liposomal formulation of SN-38, the active metabolite of irinotecan (Camptosar), a chemotherapeutic pro-drug approved for the treatment of advanced colorectal Y.